Thinking about buying stock in Leap Therapeutics, Galmed Pharmaceuticals, Livexlive Media, Catalyst Pharmaceuticals, or Oramed Pharmaceuticals?
Montag, 22.03.2021 14:35 von PR Newswire
PR Newswire
NEW YORK, March 22, 2021
NEW YORK, March 22, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LPTX, GLMD, LIVX, CPRX, and ORMP.
To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.
- LPTX: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=LPTX&prnumber=032220212
- GLMD: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=GLMD&prnumber=032220212
- LIVX: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=LIVX&prnumber=032220212
- CPRX: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=CPRX&prnumber=032220212
- ORMP: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ORMP&prnumber=032220212
(Note: You may have to copy this link into your browser then press the [ENTER] key.)
InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.
SOURCE InvestorsObserver